DIN 02461412 — MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 200 MG; 600 MG; 300 MG
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE is a tablet of Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate marketed by MYLAN PHARMACEUTICALS ULC. The full Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02461412
- Brand name
- MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
- Active ingredient
- Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate
- Strength
- 200 MG; 600 MG; 300 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- MYLAN PHARMACEUTICALS ULC
- Health Canada status
- MARKETED
- Drug class
- Non-nucleoside reverse transcriptase inhibitor (NNRTI) plus two nucleos(t)ide reverse transcriptase inhibitors (NRTIs) combination (antiretroviral)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02468247 | APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300 MG; 200 MG; 600 MG | TABLET | APOTEX INC | MARKETED |
| 02478404 | AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600 MG; 300 MG; 200 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02519461 | JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 300 MG; 200 MG; 600 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02487284 | PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600 MG; 200 MG; 300 MG | TABLET | PHARMASCIENCE INC | DORMANT |
| 02393549 | TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 600 MG; 300 MG; 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED |